Novartis AG
Change company Symbol lookup
Select an option...
NVS Novartis AG
UNM Unum Group
LLY Eli Lilly and Co
BDC Belden Inc
TTM Tata Motors Ltd
HOG Harley-Davidson Inc
SKY Skyline Champion Corp
MPX Marine Products Corp

Health Care : Pharmaceuticals | Large Cap Value
Based in Switzerland
Company profile

Novartis AG is a holding company, which provides healthcare solutions. The Company is engaged in the research, development, manufacturing and marketing of a range of healthcare products led by pharmaceuticals. The Company's segments include Innovative Medicines, Sandoz, Alcon and Corporate activities. Innovative Medicines researches, develops, manufactures, distributes and sells patented prescription medicines to develop health outcomes for patients and healthcare providers. Sandoz develops, manufactures, distributes and sells prescription medicines, as well as pharmaceutical active substances that are not protected by valid and enforceable third-party patents. Alcon researches, develops, manufactures, distributes and sells eye care products. Alcon is a provider of eye care with product offerings in eye care devices and vision care. The Company's range of products includes pharmaceuticals and oncology medicines, generic and biosimilar medicines, and eye care devices.

This security is an American depositary receipt
ADR Fees
American Depositary Receipt (ADR) Fee

ADR fees charged by custodial banks normally average from 1 to 3 cents per share. Other country fees might apply. To read more, see the Exception Fees tab at Brokerage Fees

Day's Change
-2.10 (-2.59%)
B/A Size
Day's High
Day's Low
(Heavy Day)

Today's volume of 502,502 shares is on pace to be much greater than NVS's 10-day average volume of 1,640,966 shares.


Travelers Recommends Shareholders Reject TRC Capital's "Mini-Tender" Offer

6:23 pm ET September 1, 2020 (BusinessWire) Print

The Travelers Companies, Inc. (NYSE: TRV) today announced it has been notified that TRC Capital Investment Corporation (TRC Capital) has made an unsolicited "mini-tender" offer to purchase up to 1,000,000 shares of Travelers' common stock at $106.75 per share. This offer price is approximately 4.5% below the closing share price of Travelers' common stock on Aug. 21, 2020 ($111.83), the last trading day prior to the date of the offer, and approximately 6.9% below the closing price of Travelers' common stock on Sept. 1, 2020 ($114.69).

Travelers does not endorse TRC Capital's offer and recommends that Travelers shareholders not tender their shares in response to the offer. The company is not affiliated with TRC Capital, its mini-tender offer or its mini-tender offer documents. In addition to having an offer price that is below the current market price for Travelers' shares, TRC Capital's mini-tender offer is subject to numerous conditions, including TRC Capital's ability to obtain financing and there being no decrease in the market price of Travelers' shares.

Because TRC Capital's offer is for approximately 0.39% of the outstanding shares of Travelers' common stock, the offer is not subject to many of the disclosure and procedural requirements of the Securities and Exchange Commission (SEC), which are designed to protect investors. The SEC discusses mini-tender offers on its website and explains that they could come at the detriment of investors who may inadvertently sell their shares below market value. Travelers encourages brokers and dealers, as well as other market participants, to review the SEC's letter regarding broker-dealer mini-tender offer dissemination and disclosures. The SEC also provides tips for investors when it comes to mini-tender offers.

Travelers recommends that shareholders consult with their financial advisors and use caution when evaluating TRC Capital's mini-tender offer. Shareholders who have already tendered are advised that they may withdraw their shares by providing written notice as described in TRC Capital's offer documents prior to the offer's expiration, which is currently scheduled for 12:01 a.m. EDT on Sept. 23, 2020.

Travelers requests that a copy of this press release be included with all distributions of materials relating to TRC Capital's mini-tender offer.

About Travelers

The Travelers Companies, Inc. (NYSE: TRV) is a leading provider of property casualty insurance for auto, home and business. A component of the Dow Jones Industrial Average, Travelers has approximately 30,000 employees and generated revenues of approximately $32 billion in 2019. For more information, visit

View source version on

SOURCE: The Travelers Companies, Inc.

Patrick Linehan, 917.778.6267

Abbe Goldstein, 917.778.6825
comtex tracking

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.